Maria Luisa Biondi

About Diatech Pharmacogenetics

This author has not yet filled in any details.
So far Diatech Pharmacogenetics has created 1077 blog entries.

24 09, 2021

Diatech at the Soho Italy congress
Diatech at the Soho Italy congress

Events, News

Diatech at the Soho Italy congress

Diatech Pharmacogenetics2021-09-24T17:10:01+02:00

22 09, 2021

KRAS, a new weapon for the fight against lung cancer and more

Diatech Pharmacogenetics2021-09-28T15:34:42+02:00

25 08, 2021

Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.

Diatech Pharmacogenetics2021-08-25T12:02:27+02:00

12 07, 2021

11TH AUTUMN MEETING OF THE WORKING GROUP MOLECULAR PATHOLOGY
11TH AUTUMN MEETING OF THE WORKING GROUP MOLECULAR PATHOLOGY

Events, News

11TH AUTUMN MEETING OF THE WORKING GROUP MOLECULAR PATHOLOGY

Diatech Pharmacogenetics2022-04-19T15:25:27+02:00

30 06, 2021

Lung cancer: molecular markers and new opportunities to treat the early and advanced disease

Diatech Pharmacogenetics2021-07-02T13:53:43+02:00

31 05, 2021

Utility and use of NGS in clinical oncology: ESMO recommendations for patients with metastatic cancers

Diatech Pharmacogenetics2021-05-31T15:21:48+02:00

2 04, 2021

Europe approves the first anti-PD-L1/L1 therapy for patients with MSI-H/dMMR colorectal cancer

Diatech Pharmacogenetics2021-05-04T16:16:16+02:00

25 02, 2021

A breakthrough for the targeted therapy of RET+ tumours with new selective inhibitors

Diatech Pharmacogenetics2021-03-01T15:27:20+01:00

6 01, 2021

Elena Lastraioli et. al., KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation

Diatech Pharmacogenetics2021-11-03T17:07:30+01:00

29 12, 2020

Vincenzo Formica et. al., Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases

Diatech Pharmacogenetics2020-12-29T11:28:18+01:00

Previous 234 Next